Skip to main content
. 2020 May 12;8:258. doi: 10.3389/fped.2020.00258

Table 1.

Epidemiology and clinical characteristics of five COVID-19 cases.

Case 1 Case 2 Case 3 Case 4 Case 5
Gender (M/F) F M M M M
Age (y/m) 10 m 5.6 y 8 m 1.2 y 2 m
Exposure history No Grandmother confirmed No No Parents and grandparents suspected
First clinical manifestation Paroxysmal crying, vomiting, currant jelly-like stool Abdominal pain Convulsion Vomiting, diarrhea Drowsiness and poor feeding, diarrhea
Time from illness onset to fever 30 h 2 days 6 h 5 days
Fever at presentation or prior to presentation At presentation No At presentation At presentation No
Highest temperature (°C) during the course 39.8 39 38.5 37.9
Days from illness onset to admission 1.25 2 0.25 6 3
Underlying or coexisting disease Intussusception Acute suppurative appendicitis perforation with localized peritonitis Traumatic brain injury Hydronephrosis and stone in the left kidney, rotavirus infection No
Complications Shock; MODS (liver, kidney, myocardium, blood coagulation, intestinal); acute respiratory failure No No Acute respiratory failure; acute heart failure; shock; MODS (liver, kidney, myocardium) Myocardium function damaged
Treatment
Antiviral therapy Intravenous ribavirin, aerosol inhalation of interferon Aerosol inhalation of interferon Intravenous ribavirin, aerosol inhalation of interferon Intravenous ribavirin, aerosol inhalation of interferon Aerosol inhalation of interferon
Methylprednisolone 2 mg/(kg·d) × 5d No No 2 mg/(kg·d) × 3d No
Intravenous immunoglobulin 500 mg/(kg·d) × 3d No No 500 mg/(kg·d) × 4d No
Oxygen inhalation Nasal cannula No Nasal cannula Nasal cannula No
Invasive mechanical ventilation Yes No No Yes No
Blood purification PE+CRRT No No PE+CRRT No
Length of stay (days) 36 10 14 17 15
Outcomes Died Cured Cured Cured Cured